Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-ranging study of ultra-low-dose estriol vaginal gel for vaginal dryness in postmenopausal women with vulvovaginal atrophy
2015-005787-42Phase 2Completed
- Sponsor
- ITF Pharma
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estriol in vaginal atrophy (4 arms), sponsored by ITF Pharma. Primary endpoint: Primary efficacy endpoints. Started Jul 2016; status: completed.
02
Drugs
estriol
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2015-005787-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005787-42.